This new 249-page report from Venture Planning Group provides a comprehensive analysis of the Spanish therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid and Vancomycin.
During the next five years, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
2014 Analysis of the Spanish Therapeutic Drug Monitoring TDM Market: Hospitals, Commercial Labs, Ambulatory Care Centers is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.
Contains 249 pages and 19 tables
SIMILAR MARKET STUDIES
VPGMarketResearch.com's new report is a strategic analysis of major business opportunities emerging in the Italian clinical chemistry and immunodiagnostic markets during the next five years. The report explores future trends in the German market; provides estimates of the specimen, test and sales volumes, as well as major suppliers’ sales and market ...
December 2016 | $0 | View Details >>
A 33-Country Survey of the Molecular Diagnostics Market: Sales Forecasts and Supplier Shares-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing-Strategies, Instrumentation Review, Emerging Technologies, Opportunities (DataPack)
This DataPack contains tables from VPGMarketResearch.com new report, A 33-Country Survey of the Molecular Diagnostics Market: Sales Forecasts and Supplier Shares--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing--Competitive Strategies, Instrumentation Review, Emerging Technologies, Opportunities. For pricing information on DataPack sections or individual tables, please contact Customer Service.
February 2016 | $0 | View Details >>
A 39-Country Survey of the Blood Typing, Grouping and Infectious Disease Screening Market-Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation Review, Emerging Technologies, Opportunities for Suppliers
This comprehensive 39-country report from VPGMarketResearch.com contains 1,025 pages and 387 tables. This granular report and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and to assist industry executives in developing effective ...
January 2016 | $0 | View Details >>
The North America Nuclear Medicine Therapeutics Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Nuclear Medicine Therapeutics industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Nuclear Medicine Therapeutics market analysis is ...
April 2016 | $3800 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research